-+ 0.00%
-+ 0.00%
-+ 0.00%

PERSONALIS ANNOUNCES NEW DATA FROM A LANDMARK LUNG CANCER TRIAL UTILIZING ULTRASENSITIVE MRD TESTING

Reuters·10/16/2025 13:00:04

Please log in to view news